NCT07100288 Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer
| NCT ID | NCT07100288 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Complejo Hospitalario Universitario Insular Materno Infantil |
| Condition | Ovarian Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-07-20 |
| Primary Completion | 2030-07-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-07-20 with a primary completion date of 2030-07-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis
Eligibility Criteria
Inclusion Criteria: * ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma. * FIGO 2014 stage IA-IVB. * Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy * Patients with no residual disease after surgery. * Patients with ECOG performance status 0-1. Exclusion Criteria: * ◦ Patients without epithelial ovarian cancer. * Patients with ECOG 2-4. * Patients who do not consent to participate in the study. * Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07100288 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Ovarian Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07100288 currently recruiting?
Yes, NCT07100288 is actively recruiting participants. Contact the research team at bea_0904@hotmail.com for enrollment information.
Where is the NCT07100288 trial being conducted?
This trial is being conducted at Las Palmas de Gran Canaria, Spain.
Who is sponsoring the NCT07100288 clinical trial?
NCT07100288 is sponsored by Complejo Hospitalario Universitario Insular Materno Infantil. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.